We have compared the prognostic powers of serum B2M levels with albuminuria, CysC levels, and the CKD‐EPI (CKD‐Epidemiology Collaboration) GFR equations for mortality and CKD progression. The gene discussed is B2M; the disease is chronic kidney disease.